Skip to main content
. Author manuscript; available in PMC: 2021 Sep 30.
Published in final edited form as: Ann Surg Oncol. 2011 Dec 1;19(5):1663–1669. doi: 10.1245/s10434-011-2156-7

TABLE 3.

Clinicopathologic and treatment variables

Characteristic Number (%)
Procedure
 Pancreaticoduodenectomy 31 (86.1)
 Distal pancreatectomy 4 (11.1)
 Total pancreatectomy 1 (2.8)
Portal vein resection
 Yes 7 (19.4)
 No 29 (80.6)
Splenectomy
 Yes 5 (13.9)
 No 31 (86.1)
OR time (minutes)a 312 (±14)
Blood loss (ml)a 992 (±136)
Blood transfused (units)a 0.49 (±0.17)
Pathologic T stage
 0 2 (5.6)
 1 5 (13.9)
 2 3 (8.3)
 3 26 (72.2)
Pathologic N stage
 0 30 (83.3)
 1 6 (16.7)
Nodes examineda
No. positive 0.44 ±0.18
No. negative 11.4 ± 0.33
Resection
 R0 30 (83.3)
 R1 6 (16.7)
Margin
 Anterior 0
 Posterior 4 (11.1)
 Pancreatic 2 (5.6)
 Biliary 1 (2.8)
Treatment response
 Unknown 1 (2.8)
 0–25% 11 (30.6)
 25–50% 7 (19.4)
 50–99% 15 (41.7)
 100% 2 (5.6)
a

Mean (SEM)